Abbott Integrates its CGM Technology with Tandem’s Insulin Delivery System for Improving Diabetes Management

 Abbott Integrates its CGM Technology with Tandem’s Insulin Delivery System for Improving Diabetes Management

Abbott Integrates its CGM Technology with Tandem’s Insulin Delivery System for Improving Diabetes Management

Shots:

  • The companies collaborated to develop & commercialize integrated diabetes solutions that combine Abbott’s FreeStyle Libre CGM technology with Tandem’s t:slim X2 pump to improve diabetes management
  • In Oct’2019, the two companies collaborated to their technologies for monitoring glucose without fingersticks while the current agreement covers the technical development of device integration and its commercial activities
  • The companies initially commercialize the integrated solution in the US and Canada and may expand it to other countries in the future

Click here to read full press release/ article | Ref: Abbott | Image: Diabetic Nation

Related News: Abbott and Tandem Collaborate to Explore Integrated Diabetes Solutions Improving Diabetes Management

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post